ARDT

$9.30

Market ClosedAs of Mar 17, 8:00 PM UTC

Ardent Health, Inc.

Recent News

Zacks
Mar 17, 2026

Auna S.A. Sees Strong Gains From Peru: More Upside on the Horizon

AUNA's Peru operations shine with double-digit revenue and EBITDA growth, driven by high-complexity care and expanded health plan reach.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

Auna's Mexico Operations Stabilize in Q4: How the Path Ahead Looks

AUNA's Mexico operations witness Q4 stabilization as oncology revenues jump 35% sequentially, and new insurer and ISSSTELEON deals position the business for 2026 growth.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 9, 2026

Assessing Ardent Health (ARDT) Valuation As Shares Face Recent Short Term Weakness

How Ardent Health Stock Has Been Trading Recently Ardent Health (ARDT) has been under pressure recently, with the stock showing a 5.7% decline over the past day and a 6.1% drop over the past week, keeping short term sentiment cautious. See our latest analysis for Ardent Health. At a share price of $8.90, Ardent Health’s recent 1 day and 7 day share price declines contrast with its 90 day share price return of 3.6% and a 1 year total shareholder return decline of 36.7%, suggesting short term...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 6, 2026

Ardent Health Q4 Earnings Call Highlights

Ardent Health (NYSE:ARDT) management said the company exited 2025 with improving operating momentum after implementing initiatives to address industry pressures that intensified earlier in the year. On its fourth-quarter and full-year 2025 earnings call, executives pointed to stabilization in payer-

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Mar 5, 2026

Ardent Health Inc (ARDT) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...

Ardent Health Inc (ARDT) reports a 6% revenue increase and strategic advancements, while addressing industry challenges and future growth plans.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.